These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38618935)

  • 21. Gene delivery to the eye using adeno-associated viral vectors.
    Martin KR; Klein RL; Quigley HA
    Methods; 2002 Oct; 28(2):267-75. PubMed ID: 12413426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene delivery of a viral anti-inflammatory protein to combat ocular inflammation.
    Ildefonso CJ; Jaime H; Rahman MM; Li Q; Boye SE; Hauswirth WW; Lucas AR; McFadden G; Lewin AS
    Hum Gene Ther; 2015 Jan; 26(1):59-68. PubMed ID: 25420215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.
    Narfström K; Katz ML; Bragadottir R; Seeliger M; Boulanger A; Redmond TM; Caro L; Lai CM; Rakoczy PE
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1663-72. PubMed ID: 12657607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner.
    Abbasi M; Gupta VK; Chitranshi N; Gupta V; Ranjbaran R; Rajput R; Pushpitha K; Kb D; You Y; Salekdeh GH; Parton RG; Mirzaei M; Graham SL
    Theranostics; 2021; 11(13):6154-6172. PubMed ID: 33995651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current management of uveitis-associated ocular hypertension and glaucoma.
    Kesav N; Palestine AG; Kahook MY; Pantcheva MB
    Surv Ophthalmol; 2020; 65(4):397-407. PubMed ID: 31816329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory response.
    Ildefonso CJ; Jaime H; Biswal MR; Boye SE; Li Q; Hauswirth WW; Lewin AS
    Mol Ther; 2015 May; 23(5):875-884. PubMed ID: 25698151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic aspects in hypertensive uveitis].
    Călugăru M
    J Fr Ophtalmol; 1986; 9(2):115-21. PubMed ID: 3745791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and Administration of Adeno-associated Virus Vectors for Corneal Gene Delivery.
    Song L; Bower JJ; Hirsch ML
    Methods Mol Biol; 2020; 2145():77-102. PubMed ID: 32542602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
    Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
    Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product.
    Touchard E; Benard R; Bigot K; Laffitte JD; Buggage R; Bordet T; Behar-Cohen F
    J Control Release; 2018 Sep; 285():244-251. PubMed ID: 30009894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
    Nagstrup AH
    Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma: Recent advancements and future perspectives.
    Naik S; Shreya AB; Raychaudhuri R; Pandey A; Lewis SA; Hazarika M; Bhandary SV; Rao BSS; Mutalik S
    Life Sci; 2021 Jan; 264():118712. PubMed ID: 33159955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of inflammatory glaucomas.
    Sung VC; Barton K
    Curr Opin Ophthalmol; 2004 Apr; 15(2):136-40. PubMed ID: 15021226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Golden retriever pigmentary uveitis: Vision loss, risk factors for glaucoma, and effect of treatment on disease progression.
    Jost HE; Townsend WM; Moore GE; Liang S
    Vet Ophthalmol; 2020 Nov; 23(6):1001-1008. PubMed ID: 33135836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications.
    Lugin ML; Lee RT; Kwon YJ
    ACS Nano; 2020 Nov; 14(11):14262-14283. PubMed ID: 33073995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases.
    Bastola P; Song L; Gilger BC; Hirsch ML
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32823625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glaucoma in patients with ocular inflammatory disease.
    Kuchtey RW; Lowder CY; Smith SD
    Ophthalmol Clin North Am; 2005 Sep; 18(3):421-30, vii. PubMed ID: 16054999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Visual Outcome of Glaucoma With Uveitis in a Thai Population.
    Pathanapitoon K; Smitharuck S; Kunavisarut P; Rothova A
    J Glaucoma; 2017 Mar; 26(3):247-252. PubMed ID: 27906814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma.
    Zhou Y; Pernet V; Hauswirth WW; Di Polo A
    Mol Ther; 2005 Sep; 12(3):402-12. PubMed ID: 15975850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
    Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.